Cellular FLIP inhibits myeloid cell activation by suppressing selective innate signaling

Journal of Immunology

Volumn 195, Issue 6, 2015, Pages 2612-2623

  Wu, Yu Jung ^a,b   Wu, Yung Hsuan ^b   Mo, Shu Ting ^b   Hsiao, Huey Wen ^b   He, You Wen ^c   Lai, Ming Zong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CD11B ANTIGEN; DECTIN 1; FLICE INHIBITORY PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; B7 ANTIGEN; CASP8 PROTEIN, MOUSE; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; CFLAR PROTEIN, MOUSE; HLA ANTIGEN CLASS 2; LECTIN; SMALL INTERFERING RNA; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL POPULATION; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIGEN PRESENTATION; APOPTOSIS; BIOSYNTHESIS; CYTOLOGY; DENDRITIC CELL; GENETICS; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE COUNT; METABOLISM; NEUTROPHIL; RNA INTERFERENCE; SPLENOMEGALY; T LYMPHOCYTE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIGEN PRESENTATION; ANTIGENS, CD80; ANTIGENS, CD86; APOPTOSIS; BONE MARROW CELLS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 8; DENDRITIC CELLS; ENZYME ACTIVATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HISTOCOMPATIBILITY ANTIGENS CLASS II; INFLAMMATION; INTERLEUKIN-2; LECTINS, C-TYPE; LEUKOCYTE COUNT; MICE; MICE, KNOCKOUT; MYELOID CELLS; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPLENOMEGALY; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941791388     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402944     Document Type: Article

References (48)

1. Budd, R. C., W. C. Yeh, and J. Tschopp. 2006. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6: 196-204.
2. Strasser, A., P. J. Jost, and S. Nagata. 2009. The many roles of FAS receptor signaling in the immune system. Immunity 30: 180-192.
3. Wilson, N. S., V. Dixit, and A. Ashkenazi. 2009. Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol. 10: 348-355.
4. Lavrik, I. N., and P. H. Krammer. 2012. Regulation of CD95/Fas signaling at the DISC. Cell Death Differ. 19: 36-41.
5. Yeh, W. C., A. Itie, A. J. Elia, M. Ng, H. B. Shu, A. Wakeham, C. Mirtsos, N. Suzuki, M. Bonnard, D. V. Goeddel, and T. W. Mak. 2000. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 12: 633-642.
6. Chau, H., V. Wong, N. J. Chen, H. L. Huang, W. J. Lin, C. Mirtsos, A. R. Elford, M. Bonnard, A. Wakeham, A. I. You-Ten, et al. 2005. Cellular FLICEinhibitory protein is required for T cell survival and cycling. J. Exp. Med. 202: 405-413.
7. Zhang, N., and Y. W. He. 2005. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J. Exp. Med. 202: 395-404.
8. Oberst, A., C. P. Dillon, R. Weinlich, L. L. McCormick, P. Fitzgerald, C. Pop, R. Hakem, G. S. Salvesen, and D. R. Green. 2011. Catalytic activity of the caspase-8-FLIPL complex inhibits RIPK3-dependent necrosis. Nature 471: 363-367.
9. Feoktistova, M., P. Geserick, B. Kellert, D. P. Dimitrova, C. Langlais, M. Hupe, K. Cain, M. MacFarlane, G. Häcker, and M. Leverkus. 2011. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 43: 449-463.
10. He, M. X., and Y. W. He. 2013. A role for c-FLIPL in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes. Cell Death Differ. 20: 188-197.
11. Kataoka, T., R. C. Budd, N. Holler, M. Thome, F. Martinon, M. Irmler, K. Burns, M. Hahne, N. Kennedy, M. Kovacsovics, and J. Tschopp. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-kB and Erk signaling pathways. Curr. Biol. 10: 640-648.
12. Lens, S. M., T. Kataoka, K. A. Fortner, A. Tinel, I. Ferrero, R. H. MacDonald, M. Hahne, F. Beermann, A. Attinger, H. A. Orbea, et al. 2002. The caspase 8 inhibitor c-FLIPL modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol. Cell. Biol. 22: 5419-5433.
13. Fang, L. W., T. S. Tai, W. N. Yu, F. Liao, and M. Z. Lai. 2004. Phosphatidylinositide 3-kinase priming couples c-FLIP to T cell activation. J. Biol. Chem. 279: 13-18.
14. Golks, A., D. Brenner, P. H. Krammer, and I. N. Lavrik. 2006. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kB activation. J. Exp. Med. 203: 1295-1305.
15. Koenig, A., I. A. Buskiewicz, K. A. Fortner, J. Q. Russell, T. Asaoka, Y. W. He, R. Hakem, J. E. Eriksson, and R. C. Budd. 2014. The c-FLIPL cleavage product p43FLIP promotes activation of extracellular signal-regulated kinase (ERK), nuclear factor kB (NF-kB), and caspase-8 and T cell survival. J. Biol. Chem. 289: 1183-1191.
16. Zhang, N., K. Hopkins, and Y. W. He. 2008. The long isoform of cellular FLIP is essential for T lymphocyte proliferation through an NF-kB-independent pathway. J. Immunol. 180: 5506-5511.
17. Moubarak, R. S., C. Solé, M. Pascual, H. Gutierrez, M. Llovera, M. J. Pérez-García, R. Gozzelino, M. F. Segura, V. Iglesias-Guimarais, S. Reix, et al. 2010. The death receptor antagonist FLIP-L interacts with Trk and is necessary for neurite outgrowth induced by neurotrophins. J. Neurosci. 30: 6094-6105.
18. Tai, T. S., L. W. Fang, and M. Z. Lai. 2004. c-FLICE inhibitory protein expression inhibits T-cell activation. Cell Death Differ. 11: 69-79.
19. Nakajima, A., S. Komazawa-Sakon, M. Takekawa, T. Sasazuki, W. C. Yeh, H. Yagita, K. Okumura, and H. Nakano. 2006. An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 25: 5549-5559.
20. Grambihler, A., H. Higuchi, S. F. Bronk, and G. J. Gores. 2003. cFLIP-L inhibits p38 MAPK activation: an additional anti-apoptotic mechanism in bile acidmediated apoptosis. J. Biol. Chem. 278: 26831-26837.
21. Shortman, K., and S. H. Naik. 2007. Steady-state and inflammatory dendriticcell development. Nat. Rev. Immunol. 7: 19-30.
22. Satpathy, A. T., X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
23. Merad, M., P. Sathe, J. Helft, J. Miller, and A. Mortha. 2013. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31: 563-604.
24. Hammer, G. E., and A. Ma. 2013. Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu. Rev. Immunol. 31: 743-791.
25. Willems, F., Z. Amraoui, N. Vanderheyde, V. Verhasselt, E. Aksoy, C. Scaffidi, M. E. Peter, P. H. Krammer, and M. Goldman. 2000. Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 95: 3478-3482.
26. Lepelletier, Y., R. Zollinger, C. Ghirelli, F. Raynaud, R. Hadj-Slimane, A. Cappuccio, O. Hermine, Y. J. Liu, and V. Soumelis. 2010. Toll-like receptor control of glucocorticoid-induced apoptosis in human plasmacytoid predendritic cells (pDCs). Blood 116: 3389-3397.
27. Huang, Q. Q., H. Perlman, Z. Huang, R. Birkett, L. Kan, H. Agrawal, A. Misharin, S. Gurbuxani, J. D. Crispino, and R. M. Pope. 2010. FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasis. Blood 116: 4968-4977.
28. Gordy, C., H. Pua, G. D. Sempowski, and Y. W. He. 2011. Regulation of steadystate neutrophil homeostasis by macrophages. Blood 117: 618-629.
29. Wu, Y. H., W. C. Kuo, Y. J. Wu, K. T. Yang, S. T. Chen, S. T. Jiang, C. Gordy, Y. W. He, and M. Z. Lai. 2014. Participation of c-FLIP in NLRP3 and AIM2 inflammasome activation. Cell Death Differ. 21: 451-461.
30. Kang, T.-B., T. Ben-Moshe, E. E. Varfolomeev, Y. Pewzner-Jung, N. Yogev, A. Jurewicz, A. Waisman, O. Brenner, R. Haffner, E. Gustafsson, et al. 2004. Caspase-8 serves both apoptotic and nonapoptotic roles. J. Immunol. 173: 2976-2984.
31. Yeh, J. H., S. C. Hsu, S. H. Han, and M. Z. Lai. 1998 Mitogen-activated protein kinase kinase antagonized fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression. J. Exp. Med. 188: 1795-1802.
32. Hsu, S. C., M. A. Gavrilin, M. H. Tsai, J. Han, and M. Z. Lai. 1999. p38 mitogen-activated protein kinase is involved in Fas ligand expression. J. Biol. Chem. 274: 25769-25776.
33. Stranges, P. B., J. Watson, C. J. Cooper, C. M. Choisy-Rossi, A. C. Stonebraker, R. A. Beighton, H. Hartig, J. P. Sundberg, S. Servick, G. Kaufmann, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26: 629-641.
34. Klebanoff, C. A., S. P. Spencer, P. Torabi-Parizi, J. R. Grainger, R. Roychoudhuri, Y. Ji, M. Sukumar, P. Muranski, C. D. Scott, J. A. Hall, et al. 2013. Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. J. Exp. Med. 210: 1961-1976.
35. Matsuda, S., T. Moriguchi, S. Koyasu, and E. Nishida. 1998. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273: 12378-12382.
36. Hoffmeyer, A., A. Grosse-Wilde, E. Flory, B. Neufeld, M. Kunz, U. R. Rapp, and S. Ludwig. 1999. Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor a gene expression in T lymphocytes. J. Biol. Chem. 274: 4319-4327.
37. Zhu, W., J. S. Downey, J. Gu, F. Di Padova, H. Gram, and J. Han. 2000. Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J. Immunol. 164: 6349-6358.
38. Chen, H., J. Sohn, L. Zhang, J. Tian, S. Chen, and L. F. Bjeldanes. 2014. Antiinflammatory effects of chicanine on murine macrophage by down-regulating LPS-induced inflammatory cytokines in IkBa/MAPK/ERK signaling pathways. Eur. J. Pharmacol. 724: 168-174.
39. Newton, K., and A. Strasser. 2003. Caspases signal not only apoptosis but also antigen-induced activation in cells of the immune system. Genes Dev. 17: 819-825.
40. Hedrick, S. M., I. L. Ch'en, and B. N. Alves. 2010. Intertwined pathways of programmed cell death in immunity. Immunol. Rev. 236: 41-53.
41. Maelfait, J., E. Vercammen, S. Janssens, P. Schotte, M. Haegman, S. Magez, and R. Beyaert. 2008. Stimulation of Toll-like receptor 3 and 4 induces interleukin-1b maturation by caspase-8. J. Exp. Med. 205: 1967-1973.
42. Gringhuis, S. I., T. M. Kaptein, B. A. Wevers, B. Theelen, M. van der Vlist, T. Boekhout, and T. B. Geijtenbeek. 2012. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1b via a noncanonical caspase-8 inflammasome. Nat. Immunol. 13: 246-254.
43. Zhang, H., S. Rosenberg, F. J. Coffey, Y. W. He, T. Manser, R. R. Hardy, and J. Zhang. 2009. A role for cFLIP in B cell proliferation and stress MAPK regulation. J. Immunol. 182: 207-215.
44. Motz, G. T., and G. Coukos. 2013. Deciphering and reversing tumor immune suppression. Immunity 39: 61-73.
45. Safa, A. R., and K. E. Pollok. 2011. Targeting the anti-apoptotic protein c-FLIP for cancer therapy. Cancers (Basel) 3: 1639-1671.
46. Shirley, S., and O. Micheau. 2013. Targeting c-FLIP in cancer. Cancer Lett. 332: 141-150.
47. Chen, L., and D. B. Flies. 2013. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13: 227-242.
48. Zitvogel, L., L. Galluzzi, M. J. Smyth, and G. Kroemer. 2013. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity 39: 74-88.